TGF-β, EMT, and resistance to anti-cancer treatment

Transforming growth factor-β (TGF-β) signaling regulates cell-specific programs involved in embryonic development, wound-healing, and immune homeostasis. Yet, during tumor progression, these TGF-β-mediated programs are altered, leading to epithelial cell plasticity and a reprogramming of epithelial...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in cancer biology 2023-12, Vol.97, p.1-11
Main Authors: Wang, Xuecong, Eichhorn, Pieter Johan Adam, Thiery, Jean Paul
Format: Article
Language:English
Subjects:
Carcinoma
Cell Line, Tumor
Epithelial Cells
Epithelial-Mesenchymal Transition - genetics
Humans
Signal Transduction
Transforming Growth Factor beta
Tumor Microenvironment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c362t-7bc28e4c729587411a79f1c6182da3e9364cb43dda69ceb9f2dc72a006957de53
cites cdi_FETCH-LOGICAL-c362t-7bc28e4c729587411a79f1c6182da3e9364cb43dda69ceb9f2dc72a006957de53
container_end_page 11
container_issue
container_start_page 1
container_title Seminars in cancer biology
container_volume 97
creator Wang, Xuecong
Eichhorn, Pieter Johan Adam
Thiery, Jean Paul
description Transforming growth factor-β (TGF-β) signaling regulates cell-specific programs involved in embryonic development, wound-healing, and immune homeostasis. Yet, during tumor progression, these TGF-β-mediated programs are altered, leading to epithelial cell plasticity and a reprogramming of epithelial cells into mesenchymal lineages through epithelial-to-mesenchymal transition (EMT), a critical developmental program in morphogenesis and organogenesis. These changes, in turn, lead to enhanced carcinoma cell invasion, metastasis, immune cell differentiation, immune evasion, and chemotherapy resistance. Here, we discuss EMT as one of the critical programs associated with carcinoma cell plasticity and the influence exerted by TGF-β on carcinoma status and function. We further explore the composition of carcinoma and other cell populations within the tumor microenvironment, and consider the relevant outcomes related to the programs associated with cancer treatment resistance.
doi_str_mv 10.1016/j.semcancer.2023.10.004
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2889245662</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2889245662</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-7bc28e4c729587411a79f1c6182da3e9364cb43dda69ceb9f2dc72a006957de53</originalsourceid><addsrcrecordid>eNo9kEtOwzAQhi0EoqVwBciSRRP8drxEVVuQitgUiZ3lOBMpVZMU21lwLQ7CmUjU0tWMZv6H9CH0QHBGMJFPuyxA42zrwGcUUzZcM4z5BZoSrGXKpMCX4855KpT-nKCbEHYYY80Jv0YTpjTnlIgp4tv1Kv39mSfLt-08sW2ZeAh1iGN0ErvhEuv0WJREDzY20MZbdFXZfYC705yhj9Vyu3hJN-_r18XzJnVM0piqwtEcuFNUi1xxQqzSFXGS5LS0DDST3BWclaWV2kGhK1oOWoux1EKVINgMPR5zD7776iFE09TBwX5vW-j6YGiea8qFlHSQqqPU-S4ED5U5-Lqx_tsQbEZkZmfOyMyIbHwMyAbn_amkLxooz75_RuwPzvBpdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2889245662</pqid></control><display><type>article</type><title>TGF-β, EMT, and resistance to anti-cancer treatment</title><source>Elsevier</source><creator>Wang, Xuecong ; Eichhorn, Pieter Johan Adam ; Thiery, Jean Paul</creator><creatorcontrib>Wang, Xuecong ; Eichhorn, Pieter Johan Adam ; Thiery, Jean Paul</creatorcontrib><description>Transforming growth factor-β (TGF-β) signaling regulates cell-specific programs involved in embryonic development, wound-healing, and immune homeostasis. Yet, during tumor progression, these TGF-β-mediated programs are altered, leading to epithelial cell plasticity and a reprogramming of epithelial cells into mesenchymal lineages through epithelial-to-mesenchymal transition (EMT), a critical developmental program in morphogenesis and organogenesis. These changes, in turn, lead to enhanced carcinoma cell invasion, metastasis, immune cell differentiation, immune evasion, and chemotherapy resistance. Here, we discuss EMT as one of the critical programs associated with carcinoma cell plasticity and the influence exerted by TGF-β on carcinoma status and function. We further explore the composition of carcinoma and other cell populations within the tumor microenvironment, and consider the relevant outcomes related to the programs associated with cancer treatment resistance.</description><identifier>ISSN: 1044-579X</identifier><identifier>EISSN: 1096-3650</identifier><identifier>DOI: 10.1016/j.semcancer.2023.10.004</identifier><identifier>PMID: 37944215</identifier><language>eng</language><publisher>England</publisher><subject>Carcinoma ; Cell Line, Tumor ; Epithelial Cells ; Epithelial-Mesenchymal Transition - genetics ; Humans ; Signal Transduction ; Transforming Growth Factor beta ; Tumor Microenvironment</subject><ispartof>Seminars in cancer biology, 2023-12, Vol.97, p.1-11</ispartof><rights>Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-7bc28e4c729587411a79f1c6182da3e9364cb43dda69ceb9f2dc72a006957de53</citedby><cites>FETCH-LOGICAL-c362t-7bc28e4c729587411a79f1c6182da3e9364cb43dda69ceb9f2dc72a006957de53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37944215$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Xuecong</creatorcontrib><creatorcontrib>Eichhorn, Pieter Johan Adam</creatorcontrib><creatorcontrib>Thiery, Jean Paul</creatorcontrib><title>TGF-β, EMT, and resistance to anti-cancer treatment</title><title>Seminars in cancer biology</title><addtitle>Semin Cancer Biol</addtitle><description>Transforming growth factor-β (TGF-β) signaling regulates cell-specific programs involved in embryonic development, wound-healing, and immune homeostasis. Yet, during tumor progression, these TGF-β-mediated programs are altered, leading to epithelial cell plasticity and a reprogramming of epithelial cells into mesenchymal lineages through epithelial-to-mesenchymal transition (EMT), a critical developmental program in morphogenesis and organogenesis. These changes, in turn, lead to enhanced carcinoma cell invasion, metastasis, immune cell differentiation, immune evasion, and chemotherapy resistance. Here, we discuss EMT as one of the critical programs associated with carcinoma cell plasticity and the influence exerted by TGF-β on carcinoma status and function. We further explore the composition of carcinoma and other cell populations within the tumor microenvironment, and consider the relevant outcomes related to the programs associated with cancer treatment resistance.</description><subject>Carcinoma</subject><subject>Cell Line, Tumor</subject><subject>Epithelial Cells</subject><subject>Epithelial-Mesenchymal Transition - genetics</subject><subject>Humans</subject><subject>Signal Transduction</subject><subject>Transforming Growth Factor beta</subject><subject>Tumor Microenvironment</subject><issn>1044-579X</issn><issn>1096-3650</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNo9kEtOwzAQhi0EoqVwBciSRRP8drxEVVuQitgUiZ3lOBMpVZMU21lwLQ7CmUjU0tWMZv6H9CH0QHBGMJFPuyxA42zrwGcUUzZcM4z5BZoSrGXKpMCX4855KpT-nKCbEHYYY80Jv0YTpjTnlIgp4tv1Kv39mSfLt-08sW2ZeAh1iGN0ErvhEuv0WJREDzY20MZbdFXZfYC705yhj9Vyu3hJN-_r18XzJnVM0piqwtEcuFNUi1xxQqzSFXGS5LS0DDST3BWclaWV2kGhK1oOWoux1EKVINgMPR5zD7776iFE09TBwX5vW-j6YGiea8qFlHSQqqPU-S4ED5U5-Lqx_tsQbEZkZmfOyMyIbHwMyAbn_amkLxooz75_RuwPzvBpdA</recordid><startdate>202312</startdate><enddate>202312</enddate><creator>Wang, Xuecong</creator><creator>Eichhorn, Pieter Johan Adam</creator><creator>Thiery, Jean Paul</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202312</creationdate><title>TGF-β, EMT, and resistance to anti-cancer treatment</title><author>Wang, Xuecong ; Eichhorn, Pieter Johan Adam ; Thiery, Jean Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-7bc28e4c729587411a79f1c6182da3e9364cb43dda69ceb9f2dc72a006957de53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Carcinoma</topic><topic>Cell Line, Tumor</topic><topic>Epithelial Cells</topic><topic>Epithelial-Mesenchymal Transition - genetics</topic><topic>Humans</topic><topic>Signal Transduction</topic><topic>Transforming Growth Factor beta</topic><topic>Tumor Microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Xuecong</creatorcontrib><creatorcontrib>Eichhorn, Pieter Johan Adam</creatorcontrib><creatorcontrib>Thiery, Jean Paul</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in cancer biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Xuecong</au><au>Eichhorn, Pieter Johan Adam</au><au>Thiery, Jean Paul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TGF-β, EMT, and resistance to anti-cancer treatment</atitle><jtitle>Seminars in cancer biology</jtitle><addtitle>Semin Cancer Biol</addtitle><date>2023-12</date><risdate>2023</risdate><volume>97</volume><spage>1</spage><epage>11</epage><pages>1-11</pages><issn>1044-579X</issn><eissn>1096-3650</eissn><abstract>Transforming growth factor-β (TGF-β) signaling regulates cell-specific programs involved in embryonic development, wound-healing, and immune homeostasis. Yet, during tumor progression, these TGF-β-mediated programs are altered, leading to epithelial cell plasticity and a reprogramming of epithelial cells into mesenchymal lineages through epithelial-to-mesenchymal transition (EMT), a critical developmental program in morphogenesis and organogenesis. These changes, in turn, lead to enhanced carcinoma cell invasion, metastasis, immune cell differentiation, immune evasion, and chemotherapy resistance. Here, we discuss EMT as one of the critical programs associated with carcinoma cell plasticity and the influence exerted by TGF-β on carcinoma status and function. We further explore the composition of carcinoma and other cell populations within the tumor microenvironment, and consider the relevant outcomes related to the programs associated with cancer treatment resistance.</abstract><cop>England</cop><pmid>37944215</pmid><doi>10.1016/j.semcancer.2023.10.004</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1044-579X
ispartof Seminars in cancer biology, 2023-12, Vol.97, p.1-11
issn 1044-579X
1096-3650
language eng
recordid cdi_proquest_miscellaneous_2889245662
source Elsevier
subjects Carcinoma
Cell Line, Tumor
Epithelial Cells
Epithelial-Mesenchymal Transition - genetics
Humans
Signal Transduction
Transforming Growth Factor beta
Tumor Microenvironment
title TGF-β, EMT, and resistance to anti-cancer treatment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A15%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TGF-%CE%B2,%20EMT,%20and%20resistance%20to%20anti-cancer%20treatment&rft.jtitle=Seminars%20in%20cancer%20biology&rft.au=Wang,%20Xuecong&rft.date=2023-12&rft.volume=97&rft.spage=1&rft.epage=11&rft.pages=1-11&rft.issn=1044-579X&rft.eissn=1096-3650&rft_id=info:doi/10.1016/j.semcancer.2023.10.004&rft_dat=%3Cproquest_cross%3E2889245662%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-7bc28e4c729587411a79f1c6182da3e9364cb43dda69ceb9f2dc72a006957de53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2889245662&rft_id=info:pmid/37944215&rfr_iscdi=true